These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1474164)

  • 1. Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion.
    Gomolin IH; Chapron DJ
    J Clin Pharmacol; 1992 Nov; 32(11):1028-32. PubMed ID: 1474164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of advanced age on the disposition of acetazolamide.
    Chapron DJ; Sweeney KR; Feig PU; Kramer PA
    Br J Clin Pharmacol; 1985 Mar; 19(3):363-71. PubMed ID: 3986087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.
    Sjöström PA; Kron BG; Odlind BG
    Eur J Clin Pharmacol; 1993; 45(2):135-9. PubMed ID: 8223834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
    Sweeney KR; Chapron DJ; Brandt JL; Gomolin IH; Feig PU; Kramer PA
    Clin Pharmacol Ther; 1986 Nov; 40(5):518-24. PubMed ID: 3769383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function.
    Chapron DJ; Gomolin IH; Sweeney KR
    J Clin Pharmacol; 1989 Apr; 29(4):348-53. PubMed ID: 2498399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion.
    Taft DR; Sweeney KR
    J Pharmacol Exp Ther; 1995 Aug; 274(2):752-60. PubMed ID: 7636739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
    Giacomini KM; Blaschke TF
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute renal failure on the disposition of cefoperazone.
    Katayama H; Yasuhara M; Hori R
    J Pharm Pharmacol; 1999 Mar; 51(3):361-6. PubMed ID: 10344639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro.
    Sweeney KR; Chapron DJ; Kramer PA
    J Pharm Sci; 1988 Sep; 77(9):751-6. PubMed ID: 3225768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal clearance and protein binding of melphalan in patients with cancer.
    Reece PA; Hill HS; Green RM; Morris RG; Dale BM; Kotasek D; Sage RE
    Cancer Chemother Pharmacol; 1988; 22(4):348-52. PubMed ID: 3168148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
    Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.
    Rodriguez CA; Smith DE
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2395-400. PubMed ID: 1804013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
    Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
    Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.
    Gugler R; Mueller G
    Br J Clin Pharmacol; 1978 May; 5(5):441-6. PubMed ID: 350249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased binding of verapamil to plasma proteins in patients with liver disease.
    Giacomini KM; Massoud N; Wong FM; Giacomini JC
    J Cardiovasc Pharmacol; 1984; 6(5):924-8. PubMed ID: 6209501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.